REHOVOT, Israel--(BUSINESS WIRE)--Evogene Ltd. (NYSE: EVGN) (TASE: EVGN), a plant genomics company specializing in enhancing crop productivity for the food, feed and biofuel industries, announced today the closing of its previously announced initial public offering in the United States of 5,750,000 ordinary shares at the price to the public of $14.75 per share, which includes the exercise in full by the underwriters of their option to purchase up to 750,000 additional ordinary shares. All of the shares in the offering were offered by Evogene.
Help employers find you! Check out all the jobs and post your resume.
